{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:45Z","timestamp":1786207365493,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19816-6","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:58:29Z","timestamp":1779278309000},"page":"7968-7978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of Muscle Mass Loss on Survival During Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Multi-center Retrospective Study in China (TIMES Study)"],"prefix":"10.1245","volume":"33","author":[{"given":"Guiyu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingrong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8544-9007","authenticated-orcid":false,"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"3","key":"19816_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"19816_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.20892\/j.issn.2095-3941.2016.0093","volume":"14","author":"H Liang","year":"2017","unstructured":"Liang H, Fan JH, Qiao YL. Epidemiology, etiology, and prevention of esophageal squamous cell carcinoma in China. Cancer Biol Med. 2017;14(1):33\u201341. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2016.0093.","journal-title":"Cancer Biol Med."},{"issue":"2","key":"19816_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0973-1482.82923","volume":"7","author":"MH Taziki","year":"2011","unstructured":"Taziki MH, Rajaee S, Behnampour N, Tadrisee M, Mansourian AR. Esophageal cancer: 5-year survival rate at south-east of Caspian Sea of northern Iran. J Cancer Res Ther. 2011;7(2):135\u20137. https:\/\/doi.org\/10.4103\/0973-1482.82923.","journal-title":"J Cancer Res Ther."},{"issue":"Pt 2","key":"19816_CR4","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.semcancer.2022.01.007","volume":"86","author":"X Li","year":"2022","unstructured":"Li X, Chen L, Luan S, Zhou J, Xiao X, Yang Y, et al. The development and progress of nanomedicine for esophageal cancer diagnosis and treatment. Semin Cancer Biol. 2022;86(Pt 2):873\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2022.01.007.","journal-title":"Semin Cancer Biol."},{"issue":"22","key":"19816_CR5","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074\u201384. https:\/\/doi.org\/10.1056\/NEJMoa1112088.","journal-title":"N Engl J Med."},{"issue":"27","key":"19816_CR6","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","volume":"36","author":"H Yang","year":"2018","unstructured":"Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): A phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36(27):2796\u2013803. https:\/\/doi.org\/10.1200\/JCO.2018.79.1483.","journal-title":"J Clin Oncol."},{"key":"19816_CR7","doi-asserted-by":"publisher","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https:\/\/doi.org\/10.1093\/ageing\/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601. 10.1093\/ageing\/afz046.","DOI":"10.1093\/ageing\/afy169"},{"key":"19816_CR8","doi-asserted-by":"publisher","unstructured":"Murimwa GZ, Venkat PS, Jin W, Leuthold S, Latifi K, Almhanna K, et al. Impact of sarcopenia on outcomes of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation followed by surgery. J Gastrointest Oncol. 2017;8(5):808-15. https:\/\/doi.org\/10.21037\/jgo.2017.06.11.","DOI":"10.21037\/jgo.2017.06.11"},{"issue":"7","key":"19816_CR9","doi-asserted-by":"publisher","first-page":"doy104","DOI":"10.1093\/dote\/doy104","volume":"32","author":"J Oguma","year":"2019","unstructured":"Oguma J, Ozawa S, Kazuno A, Yamamoto M, Ninomiya Y, Yatabe K. Prognostic significance of sarcopenia in patients undergoing esophagectomy for superficial esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(7):doy104. https:\/\/doi.org\/10.1093\/dote\/doy104.","journal-title":"Dis Esophagus."},{"issue":"1","key":"19816_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13014-020-01545-z","volume":"15","author":"R Mallet","year":"2020","unstructured":"Mallet R, Modzelewski R, Lequesne J, Mihailescu S, Decazes P, Auvray H, et al. Prognostic value of sarcopenia in patients treated by radiochemotherapy for locally advanced oesophageal cancer. Radiat Oncol. 2020;15(1):116. https:\/\/doi.org\/10.1186\/s13014-020-01545-z.","journal-title":"Radiat Oncol."},{"issue":"6","key":"19816_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00384-017-2773-0","volume":"32","author":"M Hanaoka","year":"2017","unstructured":"Hanaoka M, Yasuno M, Ishiguro M, Yamauchi S, Kikuchi A, Tokura M, et al. Morphologic change of the psoas muscle as a surrogate marker of sarcopenia and predictor of complications after colorectal cancer surgery. Int J Colorectal Dis. 2017;32(6):847\u201356. https:\/\/doi.org\/10.1007\/s00384-017-2773-0.","journal-title":"Int J Colorectal Dis."},{"issue":"4","key":"19816_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.3233\/BLC-180188","volume":"4","author":"KJ Rimar","year":"2018","unstructured":"Rimar KJ, Glaser AP, Kundu S, Schaeffer EM, Meeks J, Psutka SP. Changes in lean muscle mass associated with neoadjuvant platinum-based chemotherapy in patients with muscle invasive bladder cancer. Bladder Cancer. 2018;4(4):411\u20138. https:\/\/doi.org\/10.3233\/BLC-180188.","journal-title":"Bladder Cancer."},{"issue":"5","key":"19816_CR13","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s00330-014-3110-4","volume":"24","author":"C Yip","year":"2014","unstructured":"Yip C, Goh V, Davies A, Gossage J, Mitchell-Hay R, Hynes O, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol. 2014;24(5):998\u20131005. https:\/\/doi.org\/10.1007\/s00330-014-3110-4.","journal-title":"Eur Radiol."},{"issue":"3","key":"19816_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/jcsm.13462","volume":"15","author":"JY Jang","year":"2024","unstructured":"Jang JY, Oh D, Noh JM, Sun JM, Kim HK, Shim YM. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy. J Cachexia Sarcopenia Muscle. 2024;15(3):1167\u201376. https:\/\/doi.org\/10.1002\/jcsm.13462.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"1","key":"19816_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Zhou J, Xiao X, Yang Y, Luan S, Liang Z, et al. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(1):3\u201316. https:\/\/doi.org\/10.1002\/jcsm.13126.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"4","key":"19816_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/cancers12040925","volume":"12","author":"HG Yoon","year":"2020","unstructured":"Yoon HG, Oh D, Ahn YC, Noh JM, Pyo H, Cho WK, et al. Prognostic impact of sarcopenia and skeletal muscle loss during neoadjuvant chemoradiotherapy in esophageal cancer. Cancers (Basel). 2020;12(4):925. https:\/\/doi.org\/10.3390\/cancers12040925.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"19816_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/jcsm.12540","volume":"11","author":"ERC Hagens","year":"2020","unstructured":"Hagens ERC, Feenstra ML, van Egmond MA, van Laarhoven HWM, Hulshof MCCM, Boshier PR, et al. Influence of body composition and muscle strength on outcomes after multimodal oesophageal cancer treatment. J Cachexia Sarcopenia Muscle. 2020;11(3):756\u201367. https:\/\/doi.org\/10.1002\/jcsm.12540.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"4","key":"19816_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3322\/caac.21399","volume":"67","author":"TW Rice","year":"2017","unstructured":"Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. Cancer J Clin. 2017;67(4):304\u201317.","journal-title":"Cancer J Clin"},{"issue":"2","key":"19816_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/jcsm.12956","volume":"13","author":"JH Lee","year":"2022","unstructured":"Lee JH, Yoon YC, Kim HS, Cha MJ, Kim JH, Kim K, et al. Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma. J Cachexia Sarcopenia Muscle. 2022;13(2):1076\u201386. https:\/\/doi.org\/10.1002\/jcsm.12956.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"8","key":"19816_CR20","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/nu13082744","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen X, Wang Y, Liu Z, Fang Y, Peng Z, et al. Body composition measurement improved performance of GLIM criteria in diagnosing malnutrition compared to PG-SGA in ambulatory cancer patients: A prospective cross-sectional study. Nutrients. 2021;13(8):2744. https:\/\/doi.org\/10.3390\/nu13082744.","journal-title":"Nutrients."},{"key":"19816_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2023.112132","volume":"114","author":"J Wang","year":"2023","unstructured":"Wang J, Tan S, Gianotti L, Wu G. Evaluation and management of body composition changes in cancer patients. Nutrition. 2023;114:112132. https:\/\/doi.org\/10.1016\/j.nut.2023.112132.","journal-title":"Nutrition."},{"key":"19816_CR22","unstructured":"Xu M, Guo H, Zhang J, Yan K, Lu L. A new probabilistic v-net model with hierarchical spatial feature transform for efficient abdominal multi-organ segmentation. ArXiv. 2022; arXiv:2208.01382"},{"issue":"5","key":"19816_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/hepr.13308","volume":"49","author":"JH Sung","year":"2019","unstructured":"Sung JH, Uojima H, Hidaka H, Tanaka Y, Wada N, Kubota K, et al. Risk factors for loss of skeletal muscle mass in patients with cirrhosis. Hepatol Res. 2019;49(5):550\u20138. https:\/\/doi.org\/10.1111\/hepr.13308.","journal-title":"Hepatol Res."},{"issue":"5","key":"19816_CR24","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/jcsm.13541","volume":"15","author":"YX Luo","year":"2024","unstructured":"Luo YX, Zhou XH, Heng T, Yang LL, Zhu YH, Hu P, et al. Bidirectional transitions of sarcopenia states in older adults: The longitudinal evidence from CHARLS. J Cachexia Sarcopenia Muscle. 2024;15(5):1915\u201329. https:\/\/doi.org\/10.1002\/jcsm.13541.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"19816_CR25","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/jcsm.13311","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Da J, Yuan J, Zha Y. One-year change in sarcopenia was associated with cognitive impairment among haemodialysis patients. J Cachexia Sarcopenia Muscle. 2023;14(5):2264\u201374. https:\/\/doi.org\/10.1002\/jcsm.13311.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"19816_CR26","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.21873\/anticanres.14210","volume":"40","author":"MK Jang","year":"2020","unstructured":"Jang MK, Park C, Hong S, Li H, Rhee E, Doorenbos AZ. Skeletal muscle mass change during chemotherapy: A systematic review and meta-analysis. Anticancer Res. 2020;40(5):2409\u201318. https:\/\/doi.org\/10.21873\/anticanres.14210.","journal-title":"Anticancer Res"},{"issue":"3","key":"19816_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/jcm11030508","volume":"11","author":"S Onishi","year":"2022","unstructured":"Onishi S, Tajika M, Tanaka T, Yamada K, Kamiya T, Abe T, et al. Effect of body composition change during neoadjuvant chemotherapy for esophageal squamous cell carcinoma. J Clin Med. 2022;11(3):508. https:\/\/doi.org\/10.3390\/jcm11030508.","journal-title":"J Clin Med."},{"issue":"11","key":"19816_CR28","doi-asserted-by":"publisher","first-page":"doab016","DOI":"10.1093\/dote\/doab016","volume":"34","author":"PR Boshier","year":"2021","unstructured":"Boshier PR, Klevebro F, Jenq W, Puccetti F, Muthuswamy K, Hanna GB, et al. Long-term variation in skeletal muscle and adiposity in patients undergoing esophagectomy. Dis Esophagus. 2021;34(11):doab016. https:\/\/doi.org\/10.1093\/dote\/doab016.","journal-title":"Dis Esophagus."},{"issue":"12","key":"19816_CR29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s00595-019-01846-1","volume":"49","author":"N Kamitani","year":"2019","unstructured":"Kamitani N, Migita K, Matsumoto S, Wakatsuki K, Kunishige T, Nakade H, et al. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy. Surg Today. 2019;49(12):1022\u20138. https:\/\/doi.org\/10.1007\/s00595-019-01846-1.","journal-title":"Surg Today."},{"issue":"1","key":"19816_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13102-025-01276-2","volume":"17","author":"C Gong","year":"2025","unstructured":"Gong C, Feng B, Wang H, et al. Feasibility, safety and preliminary effect of exercise prehabilitation in patients with esophageal cancer undergoing surgery: an open-label, randomized, parallel-group pilot and feasibility study. BMC Sports Sci Med Rehabil. 2025;17(1):223. https:\/\/doi.org\/10.1186\/s13102-025-01276-2.","journal-title":"BMC Sports Sci Med Rehabil."},{"issue":"12","key":"19816_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamasurg.2018.1645","volume":"153","author":"EM Minnella","year":"2018","unstructured":"Minnella EM, Awasthi R, Loiselle SE, et al. Effect of exercise and nutrition prehabilitation on functional capacity in esophagogastric cancer surgery: a randomized clinical trial. JAMA Surg. 2018;153(12):1081\u20139. https:\/\/doi.org\/10.1001\/jamasurg.2018.1645.","journal-title":"JAMA Surg."},{"key":"19816_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.106206","volume":"97","author":"P Wang","year":"2022","unstructured":"Wang P, Wang S, Li X, Lin G, Ma Y, Xiao R, et al. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: a systematic review and meta-analysis. Int J Surg. 2022;97:106206. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106206.","journal-title":"Int J Surg."},{"issue":"1","key":"19816_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12885-022-09443-1","volume":"22","author":"M Amitani","year":"2022","unstructured":"Amitani M, Oba T, Kiyosawa N, Morikawa H, Chino T, Soma A, et al. Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer. BMC Cancer. 2022;22(1):327. https:\/\/doi.org\/10.1186\/s12885-022-09443-1.","journal-title":"BMC Cancer."},{"issue":"5","key":"19816_CR34","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/cancers11050709","volume":"11","author":"P Naumann","year":"2019","unstructured":"Naumann P, Eberlein J, Farnia B, Hackert T, Debus J, Combs SE. Continued weight loss and sarcopenia predict poor outcomes in locally advanced pancreatic cancer treated with chemoradiation. Cancers (Basel). 2019;11(5):709. https:\/\/doi.org\/10.3390\/cancers11050709.","journal-title":"Cancers (Basel)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19816-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19816-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:48:52Z","timestamp":1786204132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19816-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19816"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19816-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors reported a conflict of interest related to the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}